IPACK on Early Pain Scores After ACL Reconstruction
Pain, Postoperative, Anterior Cruciate Ligament Injuries, Analgesics, Opioid
About this trial
This is an interventional treatment trial for Pain, Postoperative
Eligibility Criteria
Inclusion Criteria: All patients presenting to Dr. John Miller with the Department of Orthopedic Surgery, Sports Medicine Division, at Loyola University Medical Center electing to undergo ACL reconstruction surgery. Patients 16 and over English speaking patients Patients who have the capacity to make their own medical decisions and consent to the study Exclusion Criteria: Previous surgery on the operative knee Previous knee infection Chronic opioid use Have a known allergy to local anesthetics Patient using autograft (cadaver) for ACL reconstruction.
Sites / Locations
- Loyola University Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
IPACK
Placebo
After the adductor canal block, the anesthesiologist will reposition, visualize the anatomy of the IPACK block with ultrasound, and place 1% lidocaine for skin infiltration. Once adequate needle visualization is achieved within the correct anatomic position and plane, 20mL of 0.5% bupivacaine will be injected.
After the adductor canal block, the anesthesiologist will reposition, visualize the anatomy of the IPACK block with ultrasound, and place 1% lidocaine for skin infiltration. Once adequate needle visualization is achieved within the correct anatomic position and plane, 20mL of normal saline will be injected.